tradingkey.logo

Regeneron Pharmaceuticals Inc

REGN
View Detailed Chart

529.240USD

+7.399+1.42%
Close 06/13, 16:00ETQuotes delayed by 15 min
57.26BMarket Cap
12.98P/E TTM

Regeneron Pharmaceuticals Inc

529.240

+7.399+1.42%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.42%

5 Days

+7.30%

1 Month

-7.37%

6 Months

-27.63%

Year to Date

-25.70%

1 Year

-48.94%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 28 analysts
BUY
Current Rating
735.547
Target Price
38.98%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

557
Total
5
Median
6
Average
Company name
Ratings
Analysts
Regeneron Pharmaceuticals Inc
REGN
28
CRISPR Therapeutics AG
CRSP
28
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
28
Ionis Pharmaceuticals Inc
IONS
26
Moderna Inc
MRNA
26
1
2
3
...
112

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(6)
Neutral(3)
Buy(3)
Indicators
Sell(2)
Neutral(3)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
1.464
Neutral
RSI(14)
45.547
Neutral
STOCH(KDJ)(9,3,3)
83.893
Buy
ATR(14)
23.790
High Vlolatility
CCI(14)
-0.000
Neutral
Williams %R
59.939
Sell
TRIX(12,20)
-0.607
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
522.162
Buy
MA10
505.070
Buy
MA20
546.847
Sell
MA50
563.706
Sell
MA100
622.131
Sell
MA200
757.899
Sell

News

More news coming soon, stay tuned...

Company

Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.
Ticker SymbolREGN
CompanyRegeneron Pharmaceuticals Inc
CEODr. Leonard S. Schleifer, M.D., Ph.D
Websitehttps://www.regeneron.com/
KeyAI